HUM vs RANI · P/E 39, rev $117.76B vs rev $1.0M
Humana Inc (HUM) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported RANI revenue for 2024-12-31 was $1.0M. Net income was -$56.6M. RANI currently screens at market cap $41.5M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. RANI currently screens at market cap $41.5M.
Not investment advice. Open the HUM and RANI stock pages for the full models.
Not investment advice.